BeOne Medicines
ONC
#819
Rank
A$43.72 B
Marketcap
A$421.46
Share price
2.02%
Change (1 day)
13.17%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): A$7.13

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is A$6.97. In 2025 the company made an earnings per share (EPS) of A$3.96 an increase over its 2024 EPS that were of A-$9.05.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$7.1380.15%
2025A$3.96-143.75%
2024A-$9.05
2022A-$28.2728.21%
2021A-$22.05-19.96%
2020A-$27.5520.81%
2019A-$22.8031.52%
2018A-$17.34417.57%
2017A-$3.35-37.16%
2016A-$5.33158.95%
2015A-$2.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.35-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.38-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA